Home > Qtrly Results > BAFNA PHARMACEUTICALS

BAFNA PHARMACEUTICALS
Quarterly Results Analysis [Sep2025]

AD     Remove this Ad

BAFNA PHARMACEUTICALS Quarterly Results

Standalone Sep2025
UnAudited
Jun2025
UnAudited
Mar2025
UnAudited
Dec2024
UnAudited
Sep2024
UnAudited
Jun2024
UnAudited
Mar2024
UnAudited
Dec2023
UnAudited
Revenues ₹35 Cr ₹35 Cr ₹39 Cr ₹33 Cr ₹40 Cr ₹33 Cr ₹41 Cr ₹28 Cr
Expenses ₹31 Cr ₹30 Cr ₹36 Cr ₹30 Cr ₹37 Cr ₹32 Cr ₹39 Cr ₹31 Cr
Operating Income ₹4 Cr ₹5 Cr ₹3 Cr ₹3 Cr ₹4 Cr ₹1 Cr ₹3 Cr ₹-2 Cr
Other Income ₹1 Cr ₹1 Cr ₹1 Cr ₹0 Cr ₹1 Cr ₹1 Cr ₹1 Cr ₹1 Cr
Interest ₹1 Cr ₹1 Cr ₹1 Cr ₹1 Cr ₹1 Cr ₹1 Cr ₹1 Cr ₹1 Cr
Depreciation ₹1 Cr ₹1 Cr ₹0 Cr ₹2 Cr ₹2 Cr ₹1 Cr ₹1 Cr ₹1 Cr
Profit Before Tax ₹3 Cr ₹3 Cr ₹1 Cr ₹1 Cr ₹3 Cr ₹-1 Cr ₹1 Cr ₹-3 Cr
Profit After Tax ₹3 Cr ₹3 Cr ₹1 Cr ₹1 Cr ₹3 Cr ₹-1 Cr ₹1 Cr ₹-3 Cr
EPS ₹1.32 ₹1.43 ₹0.55 ₹0.40 ₹1.11 ₹-0.31 ₹0.62 ₹-1.24
Industry Peers & Returns1W1M1Y
BAFNA PHARMACEUTICALS -0% -19.4% 45.2%
SUN PHARMACEUTICAL INDUSTRIES 1.2% -5.3% -5.6%
DIVIS LABORATORIES -3.9% -6% 11.9%
CIPLA -1.2% -12.6% -6.6%
TORRENT PHARMACEUTICALS 0.9% 3.7% 20.5%
DR REDDYS LABORATORIES -3.4% -5.7% 0.3%
MANKIND PHARMA -2.3% -4.4% -14.9%
ZYDUS LIFESCIENCES -1.9% -3.9% -3.5%
LUPIN 0.3% 1.2% 5.7%

BAFNA PHARMACEUTICALS Quarterly Revenues

Revenues
Q-o-Q

2.44 %

Y-o-Y

-12.04 %

Quarters Revenues % Change
Sep2025 ₹35 Cr
2.44
Jun2025 ₹35 Cr
-11.36
Mar2025 ₹39 Cr
17.69
Dec2024 ₹33 Cr
-17.69
Sep2024 ₹40 Cr
21.14
Jun2024 ₹33 Cr
-19.60
Mar2024 ₹41 Cr
45.55
Dec2023 ₹28 Cr -

BAFNA PHARMACEUTICALS Quarterly Operating Profit

Operating Profit
Q-o-Q

-15.51 %

Y-o-Y

12.95 %

Quarters Operating Profit % Change
Sep2025 ₹4 Cr
-15.51
Jun2025 ₹5 Cr
62.83
Mar2025 ₹3 Cr
1.67
Dec2024 ₹3 Cr
-19.25
Sep2024 ₹4 Cr
213.13
Jun2024 ₹1 Cr
-58.07
Mar2024 ₹3 Cr
Positive
Dec2023 ₹-2 Cr -
Operating Margins
Q-o-Q

-17.49 %

Y-o-Y

28.51 %

Quarters Operating Margin% % Change
Sep2025 12.08%
-17.49
Jun2025 14.64%
83.69
Mar2025 7.97%
-13.65
Dec2024 9.23%
-1.81
Sep2024 9.4%
158.24
Jun2024 3.64%
-47.85
Mar2024 6.98%
Positive
Dec2023 -7.3% -

BAFNA PHARMACEUTICALS Quarterly Profit After Tax

Profit After Tax(PAT)
Q-o-Q

-7.79 %

Y-o-Y

19.50 %

Quarters Profit After Tax % Change
Sep2025 ₹3 Cr
-7.79
Jun2025 ₹3 Cr
158.38
Mar2025 ₹1 Cr
38.40
Dec2024 ₹1 Cr
-63.76
Sep2024 ₹3 Cr
Positive
Jun2024 ₹-1 Cr
Negative
Mar2024 ₹1 Cr
Positive
Dec2023 ₹-3 Cr -
PAT Margins
Q-o-Q

-10.01 %

Y-o-Y

35.75 %

Quarters PAT Margin(%) % Change
Sep2025 8.81 %
-10.01
Jun2025 9.79 %
191.37
Mar2025 3.36 %
17.48
Dec2024 2.86 %
-55.93
Sep2024 6.49 %
Positive
Jun2024 -2.17 %
Negative
Mar2024 3.52 %
Positive
Dec2023 -10.35 % -

BAFNA PHARMACEUTICALS Quarterly Earnings Per Share (EPS)

EPS
Q-o-Q

-7.69 %

Y-o-Y

18.92 %

Quarters EPS % Change
Sep2025 ₹1.32
-7.69
Jun2025 ₹1.43
160.00
Mar2025 ₹0.55
37.50
Dec2024 ₹0.4
-63.96
Sep2024 ₹1.11
Positive
Jun2024 ₹-0.31
Negative
Mar2024 ₹0.62
Positive
Dec2023 ₹-1.24 -

You may also like the below Video Courses